BioPortfolio Logo 

BioPortfolio Bulletin

www.bioportfolio.com 

  http://www.bioportfolio.co.uk/bulletin_53.htm                                   September 14th 2004

Lead Sponsor:

  BIOPHEX delivers a unique perspective on the strategic and managerial issues that affect everyone in post-discovery development and manufacturing. The conference, produced by Genetic Engineering News, is targeted to help top-level biopharmaceutical professionals successfully transition their drug from post-discovery to market.  For more information open:

http://www.biophex.com  San Francisco Sept 28th to 30th 2004

In this Week's issue:
  • NEWS - BioNews Headlines and content - over 400 life science industry news stories per day 
  • PUBLICATIONS - DailyUpdates Publications tracker for the drug development sector
  • REPORTS - 25 new reports added in the last week
  • OPINIONS - selected items on research and drug development
NEWS - BioNews Headlines and content 
Every 30 minutes BioPortfolio updates the BioNews service with the latest news items collated from thousands of published sources.  In addition we carry full text press releases for over 300 which are added to the site daily at 12:30 GMT.

To full evaluate the service and to take advanage of our email alert service visit:

BioWatch BioNews Tracking:
http://www.bioportfolio.com/news_tracking/index.htm 

To search go to:
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?FILE=search&SAVEDB=news  

 

PUBLICATIONS. DailyUpdates the publication tracker for the drug discovery community
DailyUpdates by LeadDiscovery: the only alert service that flags breaking journal articles & press releases pre-selected for the R&D community.  Click the topic below to evaluate the headlines for the 1st September:

For further information on LeadDiscovery services go to: http://www.bioportfolio.com/LeadDiscovery/index.htm 
Headline Sponsor
 		  GENTERIC, INC. Webcast Auction - Complete State-of-the-Art Biotechnology Facility with Research and Development, Vivarium and Plant Support Equipment.  Webcast Auction Wednesday, September 15, 2004 beginning at 9:00 AM (PT). Bid Live in Alameda, CA or on DoveBid's Website. For more information, visit our website or call 800-665-1042.

http://www.dovebid.com/Auctions/AuctionDetail.asp?auctionID=2774&referraltag=genteb

Reports.  

 

Growth Strategies in Generics: Innovative and aggressive strategies and their impact on branded pharmaceuticals
‘Growth Strategies in Generics: Innovative and aggressive strategies and their impact on branded pharmaceuticals ’is a report which assesses the growth prospects of generic drugs in Europe and the US. The report gives a detailed analysis of the impact of new legislation, the strategies of the key players and market pressures on the generic and branded drug sectors. The generics market in both Europe and the US is highly dynamic.

Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology
Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology is a management report form Reuters Business Insight, this report assesses the role of targeted cancer therapies as a driver of growth in the cancer market and their future role potential. Drugs for high-severity conditions grew over the past decade at over twice the rate of drugs for low severity conditions, traditionally served by primary care blockbuster drugs.

To view details and order online go to:
http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_Business_Insight_2004.html 

 

  Molecular-Targeted Pharmacotherapy in Myeloma: Clinical and Strategic Challenges on the Road to Commercialization
An enhanced understanding of disease biology offers developers the opportunity to use niche markets such as myeloma as a reduced-risk pathway to the commercialization of molecular-targeted treatments. The identification of prospective clinical, regulatory and pharmacoeconomic challenges and the implementation of strategies to overcome these obstacles are integral to maximizing commercial rewards.

To view details and order online go to:
http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Biotechnology.html 

Maximizing Product Returns Through Reformulation: Old Molecules, New Opportunities
Pharmaceutical profit margins are being squeezed by rising costs, high promotional investment and a pipeline crisis. Alongside restoring productivity companies must implement strategies that fully exploit the commercial potential of existing molecules. Whether seeking to expand a market or protect sales following patent expiry, reformulation is one strategy available for maximizing ROI.

To view details and order online go to:
http://www.bioportfolio.com/cgi-bin/acatalog/copy_of_Datamonitor_Biotechnology.html 

HIV - From the Naïve to the Complex
As HIV therapy reaches a more mature phase, the antiretroviral market is also entering a new cycle. Companies involved will have to employ new portfolio management strategies to ensure they are optimally positioned to defend against sales erosion. Product positioning and promotional activity will become increasingly important to the successful launch and sales maintenance of new drugs.

To view details and order online go to:
http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Immune_Disorders_and_Inflammation.html

To view our collection of management reports please go to:

http://www.bioportfolio.com/cgi-bin/acatalog/sitemap.html 

 

OPINIONS   From LeadDiscovery and Datamonitor
LeadDiscovery   

 

Datamonitor  

Contact us:
Editorial and features: peter.barfoot@bioportfolio.com 

Subscriber information:
To subscribe for the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com

To unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com WITH NO SUBJECT.  The system will automatically remove your email address from the list based on your email address.  If your email has changed please email peter.barfoot@bioportfolio.com with a list of your email address and we will manually unsubscribe for you.  Thank you for your understanding.

©2004 BioPortfolio Limited - http://www.bioportfolio.com and http://www.bioportfolio.co.uk